Signals
Astrazeneca Pharma India Ltd
NSE :ASTRAZEN BSE :506820 Sector : PharmaceuticalsBuy, Sell or Hold ASTRAZEN? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
| 14 Nov 6772.95 (-4.99%) | 13 Nov 7128.65 (-3.73%) | 12 Nov 7404.55 (2.04%) | 11 Nov 7256.45 (-0.69%) | 08 Nov 7306.80 (-2.82%) | 07 Nov 7519.05 (-1.22%) | 06 Nov 7611.75 (1.62%) | 05 Nov 7490.60 (1.89%) | 04 Nov 7351.45 (-2.64%) | 01 Nov 7550.95 (-0.97%) | 31 Oct 7624.90 (3.89%) | 30 Oct 7339.10 (-0.01%) | 29 Oct 7340.00 (3.95%) | 28 Oct 7060.80 (-1.14%) | 25 Oct 7142.20 (-0.18%) | 24 Oct 7155.25 (-0.94%) | 23 Oct 7223.25 (0.45%) | 22 Oct 7190.60 (-2.73%) | 21 Oct 7392.15 (-1.70%) | 18 Oct 7520.30 (-1.40%) | 17 Oct 7627.45 (-0.29%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bearish
Medium Term Investors
Neutral
Long Term Investors
Bullish
Moving Averages
5 DMA
Bearish
7176.91
10 DMA
Bearish
7341.79
20 DMA
Bearish
7321.72
50 DMA
Bearish
7302.32
100 DMA
Bearish
7011.3
200 DMA
Bullish
6332.54
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 14, 2024 04:00 PM For Next Trading Session
| Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
|---|---|---|---|---|---|
| R3 | 7492.75 | 7311.75 | 6896.81 | - | - |
| R2 | 7311.75 | 7139.7 | 6855.52 | 7289.65 | - |
| R1 | 7042.35 | 7033.4 | 6814.24 | 6998.15 | 7177.05 |
| P | 6861.35 | 6861.35 | 6861.35 | 6839.25 | 6928.7 |
| S1 | 6591.95 | 6689.3 | 6731.66 | 6547.75 | 6726.65 |
| S2 | 6410.95 | 6583 | 6690.38 | 6388.85 | - |
| S3 | 6141.55 | 6410.95 | 6649.09 | - | - |
Key Metrics
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Astrazeneca Pharma India Ltd Quaterly Results
| INCOME | |||||
| PROFIT | |||||
| EPS |
Astrazeneca Pharma India Ltd Quaterly Results
| INCOME | 335.87 | 315.45 | 391.86 | 395.87 | 416.15 |
| PROFIT | 40.71 | 15.8 | 39.48 | 35.02 | 38.43 |
| EPS | 20.95 | 6.32 | 15.79 | -4.72 | 16.37 |
Profit & Loss (Figures in Rs. Crores)
Astrazeneca Pharma India Ltd Profit & Loss
| INCOME | |
| PROFIT | |
| EPS |
Astrazeneca Pharma India Ltd Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
| INCOME | 516.91 | 565.08 | 540.12 | 634.25 | 745.96 | 884.01 | 823.45 | 805.89 | 1077.93 | 1380.53 | |
| PROFIT | -20.84 | 5.22 | 15.77 | 25.9 | 54.41 | 72.03 | 91.72 | 59.55 | 126.25 | 149.06 | |
| EPS | 0 | 2.1 | 8.02 | 10.36 | 21.78 | 28.88 | 37.32 | 24.64 | 39.72 | 64.6 |
Balance Sheet (Figures in Rs. Crores)
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
| SOURCES OF FUNDS : | ||||||||||
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves Total | 706.92 | 583.69 | 506.39 | 451.17 | 359.44 | 295.8 | 241.93 | 217.87 | 151.01 | 145.76 |
| Total Shareholders Funds | 711.92 | 588.69 | 511.39 | 456.17 | 364.44 | 300.8 | 246.93 | 222.87 | 156.01 | 150.76 |
| Unsecured Loans | 4.59 | 7.21 | 8.63 | 12.14 | 11.84 | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 4.59 | 7.21 | 8.63 | 12.14 | 11.84 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 6.21 | 8.56 | 7.5 | 6.41 | 5.38 | 2.02 | 6.66 | 2.28 | 12.92 | 1.02 |
| Total Liabilities | 722.72 | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | 225.15 | 168.93 | 151.78 |
| APPLICATION OF FUNDS : | ||||||||||
| Gross Block | 187.13 | 179.12 | 168.83 | 159.78 | 132.84 | 119.83 | 105.85 | 102.57 | 203.76 | 191.44 |
| Less : Accumulated Depreciation | 120.45 | 110.26 | 94.34 | 78.82 | 61.31 | 45 | 30.39 | 15.73 | 106.4 | 90.46 |
| Net Block | 66.68 | 68.86 | 74.49 | 80.96 | 71.53 | 74.83 | 75.46 | 86.84 | 97.36 | 100.98 |
| Capital Work in Progress | 0.27 | 1.33 | 2.2 | 4.02 | 24.24 | 6.9 | 3.57 | 4.81 | 6.31 | 12.21 |
| Inventories | 227.88 | 190.21 | 140.22 | 159.8 | 165.15 | 118.1 | 113.15 | 57.71 | 76.73 | 86.13 |
| Sundry Debtors | 153.13 | 107.52 | 85.89 | 85.19 | 83.21 | 79.75 | 54.63 | 43 | 83.14 | 42.77 |
| Cash and Bank Balance | 505.84 | 500.48 | 448.46 | 352.35 | 252.52 | 173.3 | 125.92 | 115.58 | 76.83 | 25.08 |
| Loans and Advances | 45.86 | 37.26 | 31.1 | 21.42 | 41.44 | 33.57 | 27.22 | 35.26 | 30.37 | 109.27 |
| Total Current Assets | 932.71 | 835.47 | 705.67 | 618.76 | 542.32 | 404.72 | 320.92 | 251.55 | 267.07 | 263.26 |
| Current Liabilities | 305.23 | 336.31 | 281.06 | 257.44 | 278.24 | 222.58 | 166.61 | 157.5 | 215.71 | 222.87 |
| Provisions | 50.08 | 44.1 | 47.98 | 42.55 | 46.46 | 36.4 | 40.34 | 32.84 | 18.33 | 36.95 |
| Total Current Liabilities & Provisions | 355.31 | 380.41 | 329.04 | 299.99 | 324.7 | 258.98 | 206.95 | 190.34 | 234.05 | 259.82 |
| Net Current Assets | 577.4 | 455.06 | 376.63 | 318.77 | 217.62 | 145.74 | 113.97 | 61.21 | 33.03 | 3.44 |
| Deferred Tax Assets | 22.31 | 22.2 | 18.17 | 17.31 | 17.47 | 24.42 | 34.32 | 43.56 | 0 | 0 |
| Deferred Tax Liability | 1.06 | 1.53 | 1.87 | 2.78 | 2.83 | 1.06 | 1.77 | 3.34 | 0 | 0 |
| Net Deferred Tax | 21.25 | 20.67 | 16.3 | 14.53 | 14.64 | 23.36 | 32.55 | 40.22 | 0 | 0 |
| Other Assets | 57.12 | 58.54 | 57.9 | 56.44 | 53.63 | 51.99 | 28.04 | 32.07 | 32.24 | 35.14 |
| Total Assets | 722.72 | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | 225.15 | 168.94 | 151.77 |
| Contingent Liabilities | 137.64 | 131.62 | 121.37 | 85.66 | 67.33 | 26.77 | 7.34 | 15.97 | 16.62 | 12.26 |
Cash Flow (Figures in Rs. Crores)
| Net Profit before Tax and Extr... | 219.54 |
| Depreciation | 14.94 |
| Interest (Net) | -31.37 |
| P/L on Sales of Assets | -0.03 |
| Prov. and W/O (Net) | 6.5 |
| P/L in Forex | 0.15 |
| Total Adjustments (PBT and Ext... | -7.07 |
| Operating Profit before Workin... | 212.47 |
| Trade and 0ther Receivables | -51.18 |
| Inventories | -37.67 |
| Trade Payables | -31.37 |
| Loans and Advances | 0.56 |
| Total Adjustments (OP before W... | -128.17 |
| Cash Generated from/(used in) ... | 84.3 |
| Direct Taxes Paid | -56.43 |
| Total Adjustments(Cash Generat... | -56.43 |
| Cash Flow before Extraordinary... | 27.87 |
| Net Cash from Operating Activi... | 27.87 |
| Purchased of Fixed Assets | -10.76 |
| Sale of Fixed Assets | 0.41 |
| Interest Received | 32.09 |
| Net Cash used in Investing Act... | 21.74 |
| Of Financial Liabilities | -3.86 |
| Dividend Paid | -40 |
| Interest Paid | -0.52 |
| Net Cash used in Financing Act... | -44.38 |
Company Details
Registered Office |
|
| Address | Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road |
| City | Bangalore |
| State | Karnataka |
| Pin Code | 560045 |
| Tel. No. | 91-080-67748000 |
| Fax. No. | 91-080-67748557 |
| comp.secy@astrazeneca.com | |
| Internet | http://www.astrazeneca.in |
Registrars |
|
| Address | Blk N1 12th Flr Manyata Embass |
| City | Bangalore |
| State | Karnataka |
| Pin Code | 560045 |
| Tel. No. | 91-080-67748000 |
| Fax. No. | 91-080-67748557 |
| comp.secy@astrazeneca.com | |
| Internet | http://www.astrazeneca.in |
Management |
|
| Name | Designation |
| Narayan K Seshadri | Chairman & Independent Directo |
| Revathy Ashok | Non-Exec. & Independent Dir. |
| Shilpa Divekar Nirula | Non-Exec. & Independent Dir. |
| Sanjeev Panchal | Managing Director |
| Hooi Bien Chuah | Non Executive Director |
| Sylvia Lorena Varela Ramon | Non Executive Director |
| Bhavana Agrawal | Executive Director |
